CXS
...from the AFR, I don't have full access to the site:
"ChemGenex Pharmaceuticals is possibly facing a raft of earnings downgrades after it delivered a shock to the system on Tuesday on news that its lead drug candidate is unlikely to get approval from US health regulators."
